Citation Tools
Inflammatory bowel disease
Original article
Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study